US Biotech Faces VC Slowdown, but Startups Adapt with New Strategies 2 years ago AnaIn Biopharma HighlightsFunding RoundsTop StoriesVenture Capital
Vertex and CRISPR Therapeutics Secure First-Ever FDA Approval for CRISPR-Based Therapy in Sickle Cell Disease 2 years ago AnaIn Biopharma HighlightsFDA ApprovalsResearch UpdatesTop Stories
Griffith University Launches $14M Clinical Trial for Spinal Cord Injury Using Nasal Cell Transplants 2 years ago AnaIn Clinical Trials
Replicor Secures $180M Series C to Expand RNA Amplification Platform Beyond Hepatitis B 2 years ago AnaIn Pharma Industry UpdatesTop StoriesVenture Capital
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS 2 years ago AnaIn FDA ApprovalsInvestmentsPharma Industry Updates
mRNA-4157/V940 Shows Durable Response in Melanoma: Moderna and Merck’s Cancer Vaccine Hits Key Milestone 2 years ago AnaIn Clinical TrialsPharma Industry Updates
